Literature DB >> 8502369

Monitoring of general knowledge: evidence for preservation in early Alzheimer's disease.

L Bäckman1, B Lipinska.   

Abstract

The ability to retrieve and monitor factual information was examined in normal old adults and patients with a mild Alzheimer's disease (AD). Subjects were given free recall and multiple-choice recognition tests of 48 general knowledge questions. For both tests, subjects made confidence ratings regarding the certainty of their answers, and they also made feeling-of-knowing ratings for those questions they did not answer in recall. Results indicated a superiority of controls over patients in recall that was somewhat reduced in recognition. However, there were no group differences in any of the slopes relating rating to accuracy: recall and recognition as a function of confidence rating, and recognition of questions not answered in recall as a function of feeling-of-knowing. This pattern of outcome indicates that early AD is associated with a deficit in fact-retrieval, although the ability to monitor stored general knowledge may be intact.

Entities:  

Mesh:

Year:  1993        PMID: 8502369     DOI: 10.1016/0028-3932(93)90157-u

Source DB:  PubMed          Journal:  Neuropsychologia        ISSN: 0028-3932            Impact factor:   3.139


  11 in total

1.  Alzheimer's disease can spare local metacognition despite global anosognosia: revisiting the confidence-accuracy relationship in episodic memory.

Authors:  David A Gallo; Stefanie J Cramer; Jessica T Wong; David A Bennett
Journal:  Neuropsychologia       Date:  2012-06-18       Impact factor: 3.139

Review 2.  Metamemory experiments in neurological populations: a review.

Authors:  Jasmeet K Pannu; Alfred W Kaszniak
Journal:  Neuropsychol Rev       Date:  2005-09       Impact factor: 7.444

3.  Alzheimer's disease and memory-monitoring impairment: Alzheimer's patients show a monitoring deficit that is greater than their accuracy deficit.

Authors:  Chad S Dodson; Maggie Spaniol; Maureen K O'Connor; Rebecca G Deason; Brandon A Ally; Andrew E Budson
Journal:  Neuropsychologia       Date:  2011-05-19       Impact factor: 3.139

4.  The use of metacognitive strategies to decrease false memories in source monitoring in patients with mild cognitive impairment.

Authors:  Rebecca G Deason; Neil A Nadkarni; Michelle J Tat; Sean Flannery; Bruno Frustace; Brandon A Ally; Andrew E Budson
Journal:  Cortex       Date:  2017-02-03       Impact factor: 4.027

5.  Response bias and response monitoring: Evidence from healthy older adults and patients with mild Alzheimer's disease.

Authors:  Rebecca G Deason; Michelle J Tat; Sean Flannery; Prabhakar S Mithal; Erin P Hussey; Eileen T Crehan; Brandon A Ally; Andrew E Budson
Journal:  Brain Cogn       Date:  2017-09-17       Impact factor: 2.310

6.  Preserved metamemorial ability in patients with mild Alzheimer's disease: shifting response bias.

Authors:  Jill D Waring; Hyemi Chong; David A Wolk; Andrew E Budson
Journal:  Brain Cogn       Date:  2007-06-18       Impact factor: 2.310

7.  An evaluation of recollection and familiarity in Alzheimer's disease and mild cognitive impairment using receiver operating characteristics.

Authors:  Brandon A Ally; Carl A Gold; Andrew E Budson
Journal:  Brain Cogn       Date:  2008-12-19       Impact factor: 2.310

8.  Objective metamemory testing captures awareness of deficit in Alzheimer's disease.

Authors:  Stephanie Cosentino; Janet Metcalfe; Brady Butterfield; Yaakov Stern
Journal:  Cortex       Date:  2007-10       Impact factor: 4.027

9.  Education level predicts retrospective metamemory accuracy in healthy aging and Alzheimer's disease.

Authors:  Jacquelyn Szajer; Claire Murphy
Journal:  J Clin Exp Neuropsychol       Date:  2013-10-16       Impact factor: 2.475

10.  Retrospective metamemory monitoring of semantic memory in community-dwelling older adults with subjective cognitive decline and mild cognitive impairment.

Authors:  Susan Y Chi; Elizabeth F Chua; Dustin W Kieschnick; Laura A Rabin
Journal:  Neuropsychol Rehabil       Date:  2020-10-26       Impact factor: 2.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.